Literature DB >> 15036253

Anatomy of the estrogen response element.

Christian J Gruber1, Doris M Gruber, Isabel M L Gruber, Fritz Wieser, Johannes C Huber.   

Abstract

Estrogens exert their regulatory potential on gene expression through different nuclear and non-nuclear mechanisms. A direct nuclear approach is the interaction of estrogen with specific target sequences of DNA, estrogen response elements (ERE) or units. EREs can be grouped into perfect and imperfect palindromic sequences with the imperfect sequences differing from the consensus sequence in one or more nucleotides and being less responsive to the activated estrogen-estrogen receptor (ER) complex. Differences in the ERE sequence and the ER subtype involved can substantially alter ER-ERE interaction. In addition, cross-talk between ERs and other nuclear transcription factors profoundly influences gene expression. Here, we focus on the recent advances in the understanding of the structure of EREs and how ERs are recruited to these. Identifying known target genes for estrogen action could help us to understand the potential risks and benefits of the administration of this steroid to humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036253     DOI: 10.1016/j.tem.2004.01.008

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  87 in total

1.  Molecular cloning, characterization, and chromosome mapping of reptilian estrogen receptors.

Authors:  Yoshinao Katsu; Kazumi Matsubara; Satomi Kohno; Yoichi Matsuda; Michihisa Toriba; Kaori Oka; Louis J Guillette; Yasuhiko Ohta; Taisen Iguchi
Journal:  Endocrinology       Date:  2010-10-06       Impact factor: 4.736

2.  Chronic hypoxia during gestation causes epigenetic repression of the estrogen receptor-α gene in ovine uterine arteries via heightened promoter methylation.

Authors:  Chiranjib Dasgupta; Man Chen; Haitao Zhang; Shumei Yang; Lubo Zhang
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

3.  Computational method for discovery of estrogen responsive genes.

Authors:  Suisheng Tang; Sin Lam Tan; Suresh Kumar Ramadoss; Arun Prashanth Kumar; Man-Hung Eric Tang; Vladimir B Bajic
Journal:  Nucleic Acids Res       Date:  2004-12-01       Impact factor: 16.971

Review 4.  Multiple pathways transmit neuroprotective effects of gonadal steroids.

Authors:  Damani N Bryant; Laird C Sheldahl; Lisa K Marriott; Robert A Shapiro; Daniel M Dorsa
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

5.  Characterization of sea bass FSHβ 5' flanking region: transcriptional control by 17β-estradiol.

Authors:  Borja Muriach; Manuel Carrillo; Silvia Zanuy; José Miguel Cerdá-Reverter
Journal:  Fish Physiol Biochem       Date:  2013-11-23       Impact factor: 2.794

Review 6.  Diverse actions of estradiol on anorexigenic and orexigenic hypothalamic arcuate neurons.

Authors:  Todd L Stincic; Oline K Rønnekleiv; Martin J Kelly
Journal:  Horm Behav       Date:  2018-04-21       Impact factor: 3.587

7.  Lack of ligand-selective binding of the aryl hydrocarbon receptor to putative DNA binding sites regulating expression of Bax and paraoxonase 1 genes.

Authors:  Danica E DeGroot; Ai Hayashi; Michael S Denison
Journal:  Arch Biochem Biophys       Date:  2013-11-04       Impact factor: 4.013

8.  Proteomics analysis of the estrogen receptor alpha receptosome.

Authors:  Ivan Nalvarte; Thomas Schwend; Jan-Ake Gustafsson
Journal:  Mol Cell Proteomics       Date:  2010-03-27       Impact factor: 5.911

9.  Neuroprotective effects of estradiol on motoneurons in a model of rat spinal cord embryonic explants.

Authors:  Andrea Cardona-Rossinyol; Margalida Mir; Víctor Caraballo-Miralles; Jerònia Lladó; Gabriel Olmos
Journal:  Cell Mol Neurobiol       Date:  2013-01-16       Impact factor: 5.046

Review 10.  Cross-talk between membrane-initiated and nuclear-initiated oestrogen signalling in the hypothalamus.

Authors:  T A Roepke; J Qiu; M A Bosch; O K Rønnekleiv; M J Kelly
Journal:  J Neuroendocrinol       Date:  2009-03       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.